News for 'India's Food and Drug Administration'

Markets end lower on Bihar verdict; Nifty holds 7,900

Markets end lower on Bihar verdict; Nifty holds 7,900

Rediff.com9 Nov 2015

TCS, Infosys and Wipro were down 0.4-2% each. Capital goods majors also ended lower with L&T and BHEL down 1.4-3.9% each.

Markets end flat amid volatile trade

Markets end flat amid volatile trade

Rediff.com17 Sep 2013

Markets ended flat on Tuesday, amid a volatile trading session, as investors exercised caution ahead of the two-day FOMC meet starting today and Reserve Bank of India's monetary policy later this week.

'Khalistanis are a microscopic minority in Punjab'

'Khalistanis are a microscopic minority in Punjab'

Rediff.com4 Apr 2023

'The Khalistanis get bulk of the money from abroad.' 'Where did Amritpal's Mercedes come from, which costs well over Rs 60 lakhs?' 'Where does his fleet of vehicles come from?' 'Local Punjabis can certainly not contribute this kind of money.'

Momos: Safe or not?

Momos: Safe or not?

Rediff.com29 Jun 2017

Jammu and Kashmir MLA Ramesh Arora wants momos banned, but are they really unhygienic and harmful?

Sensex ends over 200 points lower on weak European cues

Sensex ends over 200 points lower on weak European cues

Rediff.com28 Sep 2015

Investors will maintain a cautious stance.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

Markets make handsome gains on December F&O expiry

Markets make handsome gains on December F&O expiry

Rediff.com31 Dec 2015

The top gainers on the Sensex are Gail(India), HDFC, Infosys.

2017 begins with a bang for outbound M&A deals

2017 begins with a bang for outbound M&A deals

Rediff.com31 Jan 2017

Indian companies have made acquisitions of $1 billion so far in January

Yoga, moong soup... in govt's Covid health document

Yoga, moong soup... in govt's Covid health document

Rediff.com15 Dec 2021

With the threat of COVID-19 pandemic continuing to loom over the world, the Ministry of Ayush has come out with a comprehensive document putting forth the concept of 'holistic health'.

Crocin Quick gives GSK a headache

Crocin Quick gives GSK a headache

Rediff.com27 Sep 2005

Sensex, Nifty at their lowest close in 2015; bluechips drag

Sensex, Nifty at their lowest close in 2015; bluechips drag

Rediff.com8 Jun 2015

Markets ended their lowest close in 2015 on fears of FII outflows as the US Fed may hike rates.

Suspected human hair in tablet cited in Ranbaxy ban

Suspected human hair in tablet cited in Ranbaxy ban

Rediff.com18 Sep 2013

Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

When it comes to pharma, Made in Gujarat is a success story

When it comes to pharma, Made in Gujarat is a success story

Rediff.com2 Jun 2016

The percentage of non-standard quality drugs in the state has been in the range of 2-2.5% as compared to an all-India average of 5-6%

Earning woes drag markets lower; TCS, HUL lead fall

Earning woes drag markets lower; TCS, HUL lead fall

Rediff.com14 Oct 2015

Earning woes drag markets lower; TCS, HUL lead fall.

Rate-cut hopes drive markets higher; bluechips gain

Rate-cut hopes drive markets higher; bluechips gain

Rediff.com15 May 2015

Benchmark indices finished higher on hopes of economic reforms

Samvat 2072: Auto sector could see faster recovery

Samvat 2072: Auto sector could see faster recovery

Rediff.com11 Nov 2015

Samvat 2072: Auto sector could see faster recovery

Plasma therapy isn't proven treatment for COVID-19: Govt

Plasma therapy isn't proven treatment for COVID-19: Govt

Rediff.com29 Apr 2020

Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.

Weak oil prices drag markets; Nifty ends below 7,400

Weak oil prices drag markets; Nifty ends below 7,400

Rediff.com3 Feb 2016

Financials were the top losers while oil shares also declined amid weak crude oil prices.

Noodle crisis: Labelling dispute lands Nestle in hot water

Noodle crisis: Labelling dispute lands Nestle in hot water

Rediff.com9 Jun 2015

Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn

Centre set to seek Rs 426 cr in damages from Nestl

Centre set to seek Rs 426 cr in damages from Nestl

Rediff.com11 Aug 2015

The complaint is against Nestle's 'unfair trade practices'.

My worry is whether a child is consuming excessive lead: FSSAI CEO

My worry is whether a child is consuming excessive lead: FSSAI CEO

Rediff.com7 Aug 2015

Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.

Sensex, Nifty Bank end at record highs

Sensex, Nifty Bank end at record highs

Rediff.com19 Jun 2017

On BSE, 1,469 shares fell and 1,200 shares rose. A total of 190 shares were unchanged.

Sun gets US trade regulator nod for Ranbaxy merger

Sun gets US trade regulator nod for Ranbaxy merger

Rediff.com1 Feb 2015

Torrent to buy Ranbaxy's anti-bacterial generic

Sensex drops 371 points to end at 1-week low; financial shares drag

Sensex drops 371 points to end at 1-week low; financial shares drag

Rediff.com28 Mar 2016

The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.

Markets lose glitter ahead of Diwali as Bihar, US Fed play spoilsport

Markets lose glitter ahead of Diwali as Bihar, US Fed play spoilsport

Rediff.com10 Nov 2015

Sensex,Nifty to remain under pressure through the week.

Religare's banking bid under Ranbaxy cloud

Religare's banking bid under Ranbaxy cloud

Rediff.com1 Jun 2013

Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.

Sensex rallies 259 points to end at 2-week high

Sensex rallies 259 points to end at 2-week high

Rediff.com30 Nov 2016

HSBC maintained "overweight" rating on Indian equities, saying "fundamentals are strong".

Don't need to sell assets, can pay fine: Ranbaxy brothers

Don't need to sell assets, can pay fine: Ranbaxy brothers

Rediff.com25 May 2016

In 2013, Daiichi had launched the arbitration proceedings in Singapore.

Sensex ends below 26K on ECB move; bluechips end in red

Sensex ends below 26K on ECB move; bluechips end in red

Rediff.com4 Dec 2015

Indian markets ended on a lower note after the stimulus announced by the European Central Bank (ECB) failed to meet expectation.

Sensex ends shy of 26K ahead of US Fed meet; Metal shares drag

Sensex ends shy of 26K ahead of US Fed meet; Metal shares drag

Rediff.com23 Nov 2015

The winter session of Parliament will commence on November 26.

Pharma sector can be a good bet

Pharma sector can be a good bet

Rediff.com17 Nov 2015

Analysts say those taking exposure through stocks could look at firms focused on domestic business

Profit booking, global cues subdue markets; Nifty holds 8,300

Profit booking, global cues subdue markets; Nifty holds 8,300

Rediff.com8 Jul 2016

Midcap stocks continued to remain on buyers' radar with BSE Midcap index up 0.1%.

40 years ago and now: How Ranbaxy moved out of family control

40 years ago and now: How Ranbaxy moved out of family control

Rediff.com22 Oct 2014

Ranbaxy did its maiden public issue in 1973.

Maggi banned in Delhi, pulled out of Big Bazaar outlets

Maggi banned in Delhi, pulled out of Big Bazaar outlets

Rediff.com3 Jun 2015

Maggi banned in Delhi for 15 days.

Bloodbath on D-Street; Rs 6 lakh crore vanishes in 7 days

Bloodbath on D-Street; Rs 6 lakh crore vanishes in 7 days

Rediff.com27 Sep 2017

In the longest losing streak of 2017, the BSE Sensex has lost 1,270 points, or 3.91 per cent. It fell to a three-month low of 31,154.03 on Wednesday.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Just what the doctor ordered

Just what the doctor ordered

Rediff.com22 Apr 2017

'Indian doctors have also been wary of patients learning about drugs and brand names.' 'Probably harking back to the Brahmanical tradition of preserving information and knowledge from getting polluted by the lower classes,' says Ambi Parameswaran.

Markets at lifetime high; Nifty above 8K for first time

Markets at lifetime high; Nifty above 8K for first time

Rediff.com1 Sep 2014

The benchmark Nifty rallied 1,000 points or 17% from 7,000 in 78 trading sessions since May 12, till date to surpass the 8,000 mark.

Sensex gains 65 points; Nifty ends above 8,100

Sensex gains 65 points; Nifty ends above 8,100

Rediff.com12 Sep 2014

The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.